BioNTech SE (BNTX)

NASDAQ HEALTHCARE
$92.14 +1.33% RSI 45 Neutral Add Alert

Moving Averages

SMA 200
$102.22
Price below

Company Profile

BioNTech SE, a biotechnology company, develops and markets immunotherapies for cancer and other infectious diseases. The company is headquartered in Mainz, Germany.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$23.80B
P/E Ratio
None
EPS
$-5.96
Beta
1.371
Dividend Yield
0.00%
52-Week High
$124
52-Week Low
$79.52

Similar stocks in BIOTECHNOLOGY

VRTX
Vertex Pharmaceuticals Inc
RSI 48.0
CRSP
CRISPR Therapeutics AG
RSI 47.0
MRNA
Moderna Inc
RSI 43.0
VKTX
Viking Therapeutics Inc
RSI 47.0
SRPT
Sarepta Therapeutics Inc
RSI 33.0
EDIT
Editas Medicine Inc
RSI 47.0
IOVA
Iovance Biotherapeutics Inc
RSI 62.0
NVAX
Novavax Inc
RSI 54.0
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 53.0
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 42.0

Data last updated: May 12, 2026 at 2:08 AM EDT

Track BNTX for free

Get e-mail RSI alerts when BioNTech SE enters oversold or overbought territory. Free forever.

Add Alert